Study to Determine the Efficacy of Bendamustin in Patients With Recurrent Small Cell Lung Cancer (SCLC)
The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2001 by Charite University, Berlin, Germany.
Recruitment status was Recruiting
Recruitment status was Recruiting
Sponsor:
Charite University, Berlin, Germany
Collaborator:
ribosepharm GmbH
Information provided by:
Charite University, Berlin, Germany
ClinicalTrials.gov Identifier:
NCT00168922
First received: September 9, 2005
Last updated: April 27, 2006
Last verified: January 2001
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | December 2006 |
| Estimated Primary Completion Date: | No date given |